Primary pulmonary malignancy | No primary pulmonary malignancy identified | |
---|---|---|
Onconeuronal and antineuronal | 5 | 6 |
antibodies (n = 11) | (45%) | (54%) |
No onconeuronal and antineuronal | 6 | 4 |
antibodies present (n = 10) | (60%) | (40%) |
Well-defined onconeuronal | 3 | 2 |
antibodies (n = 5) | (60%) | (40%) |
No well-defined onconeuronal | 8 | 8 |
antibodies present (n = 16) | (50%) | (50%) |